Spero Therapeutics Inc
SPRONASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$2.92
Day High
$2.92
Day Low
$2.75
Prev. Close
$2.90
VolumeShares traded today.
1.32M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$163.86M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
16.41
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$3.22
52W LowLowest price over the past 52 weeks.
$1.80
50D MAAverage closing price over the last 50 trading days.
$2.61
200D MAAverage closing price over the last 200 trading days.
$2.34
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+5.2%1M
+11.9%6M
+20.9%YTD
+20.4%1Y
+3.3%About
The Biomedical Advanced Research and Development Authority (BARDA) is a center within the Administration for Strategic Preparedness and Response (ASPR) located within the U.S. Department of Health and Human Services (HHS) responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA). The ASPR center manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks.
sperotherapeutics.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade SPRO
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.